makes ilns portfolio more valuable, the key is the tau, this is a huge overreaction of sellers being scared out oftheir shares. in addition johnson and johnson is still developing bapi in ph3 for mac degeneration . we are also not far away from our next milestone payment from viropharma of 10 mill imo for orphan status of ox1 . i'm expecting an update in the form of shareholder letter any minute now detailing all of this and much more imo. i've added 2.2 mill shares today to my holdings, this will correct itself big time very soon and very fast. this is the way u make money with emerging biotechs, buy on the cheap from weak scared hands/overreaction.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.